Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for ARDX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 249.15M
March 31, 2026 246.97M
December 31, 2025 244.35M
September 30, 2025 242.97M
June 30, 2025 240.77M
March 31, 2025 239.20M
December 31, 2024 238.02M
September 30, 2024 236.89M
June 30, 2024 235.40M
March 31, 2024 233.96M
December 31, 2023 232.45M
September 30, 2023 232.13M
June 30, 2023 217.86M
March 31, 2023 214.46M
December 31, 2022 198.58M
September 30, 2022 187.40M
June 30, 2022 153.80M
March 31, 2022 136.33M
December 31, 2021 130.18M
September 30, 2021 106.77M
June 30, 2021 102.97M
March 31, 2021 98.69M
December 31, 2020 93.60M
September 30, 2020 90.24M
June 30, 2020 89.14M
Date Value
March 31, 2020 89.04M
December 31, 2019 88.82M
September 30, 2019 62.88M
June 30, 2019 62.80M
March 31, 2019 62.60M
December 31, 2018 62.52M
September 30, 2018 62.11M
June 30, 2018 62.05M
March 31, 2018 47.60M
December 31, 2017 47.54M
September 30, 2017 47.50M
June 30, 2017 47.44M
March 31, 2017 47.39M
December 31, 2016 47.31M
September 30, 2016 47.30M
June 30, 2016 34.65M
March 31, 2016 34.63M
December 31, 2015 25.96M
September 30, 2015 25.95M
June 30, 2015 25.91M
March 31, 2015 18.64M
December 31, 2014 18.59M
September 30, 2014 18.40M
June 30, 2014 18.34M
March 31, 2014

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
REGENXBIO, Inc. 54.16M
ACADIA Pharmaceuticals, Inc. 172.13M
Alnylam Pharmaceuticals, Inc. 133.73M
Anika Therapeutics, Inc. 13.38M
Savara, Inc. 205.40M